Accenture (ACN) lowered its fiscal 2026 revenue growth outlook and forecast Q4 revenue below market expectations on Thursday, according to an earnings statement and data compiled by FactSet.

Shares sank past 18%, with intraday trading volume soaring to more than 21 million from a daily average of about 6.07 million.

Kroger (KR) reported fiscal Q1 adjusted earnings per share that narrowly missed analysts' estimates, according to an earnings statement on Thursday and FactSet-compiled data. Wells Fargo adjusted the price target for the company's shares to $58 from $68.

Shares dropped 8.4% as intraday trading volume jumped to 12.1 million from the stock's daily average of about 6.18 million.

NovoCure's (NVCR) phase 3 trial evaluating its tumor-treating fields therapy in patients with newly diagnosed glioblastoma failed to meet its primary endpoint, the company said Thursday.

Shares slumped past 18% amid a surge in intraday trading volume to about 2.61 million from a daily average of roughly 1.52 million.